Anastasios A Tsiatis

A generalized logrank-type test for comparison of treatment regimes in sequential multiple assignment randomized trials

BIOMETRICS, 80(4).

Group sequential methods for interim monitoring of randomized clinical trials with time-lagged outcome

Tsiatis, A. A., & Davidian, M. (2022, September 18). STATISTICS IN MEDICINE, Vol. 9.

Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials

[Review of ]. JOURNAL OF INFECTIOUS DISEASES, 224(12), 1995–2000.

Estimating vaccine efficacy over time after a randomized study is unblinded

Tsiatis, A. A., & Davidian, M. (2021, August 13). BIOMETRICS, Vol. 8.

Estimation of the odds ratio in a proportional odds model with censored time-lagged outcome in a randomized clinical trial

Tsiatis, A. A., Davidian, M., & Holloway, S. T. (2021, December 17). BIOMETRICS, Vol. 12.

Rejoinder: Estimating vaccine efficacy over time after a randomized study is unblinded

Tsiatis, A. A., & Davidian, M. (2021, August 22). BIOMETRICS, Vol. 8.

Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF Registry

Cools, F., Johnson, D., Camm, A. J., Bassand, J.-P., Verheugt, F. W. A., Yang, S., … Kakkar, A. K. (2021, July 23). JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 7.

Independent increments in group sequential tests: a review

[Review of ]. SORT-STATISTICS AND OPERATIONS RESEARCH TRANSACTIONS, 44(2), 223–264.

Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia

[Review of ]. ANNALS OF ONCOLOGY, 30(4), 542–550.

Dynamic Treatment Regimes

Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes

DIABETES CARE, 42(2), 192–199.

Interpretable Dynamic Treatment Regimes

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 113(524), 1541–1549.

Modeling survival distribution as a function of time to treatment discontinuation: A dynamic treatment regime approach

BIOMETRICS, 74(3), 900–909.

Optimal two-stage dynamic treatment regimes from a classification perspective with censored survival data

BIOMETRICS, 74(4), 1180–1192.

Effect of oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes a randomized clinical trial

Journal of the American Medical Association, 318(19), 1891–1902.

Optimal treatment regimes for survival endpoints using locally-efficient doubly-robust estimator from a classification perspective

Lifetime Data Analysis, 23(4), 585–604.

Survival benefit of lung transplantation in the modern era of lung allocation

Annals of the American Thoracic Society, 14(2), 172–181.

A log rank type test in observational survival studies with stratified sampling

LIFETIME DATA ANALYSIS, 22(2), 280–298.

Estimating optimal treatment regimes from a classification perspective (vol 1, pg 103, 2012)

STAT, Vol. 5, pp. 278–278.

Estimation After a Group Sequential Trial

STATISTICS IN BIOSCIENCES, 7(2), 187–205.

Using Decision Lists to Construct Interpretable and Parsimonious Treatment Regimes

BIOMETRICS, 71(4), 895–904.

Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy

Statistics in Medicine, 35(8), 1245–1256.

Combining Biomarkers to Optimize Patient Treatment Recommendations Discussions

Laber, E. B., Tsiatis, A. A., Davidian, M., & Holloway, S. T. (2014, September). BIOMETRICS, Vol. 70, pp. 707–710.

On random sample size, ignorability, ancillarity, completeness, separability, and degeneracy: Sequential trials, random sample sizes, and missing data

STATISTICAL METHODS IN MEDICAL RESEARCH, 23(1), 11–41.

Q- and A-Learning Methods for Estimating Optimal Dynamic Treatment Regimes

STATISTICAL SCIENCE, 29(4), 640–661.

Assessing the Causal Effect of Organ Transplantation on the Distribution of Residual Lifetime

BIOMETRICS, 69(4), 820–829.

Doubly-Robust Estimators of Treatment-Specific Survival Distributions in Observational Studies with Stratified Sampling

BIOMETRICS, 69(4), 830–839.

Efficient estimation of the distribution of time to composite endpoint when some endpoints are only partially observed

LIFETIME DATA ANALYSIS, 19(4), 513–546.

Robust estimation of optimal dynamic treatment regimes for sequential treatment decisions

BIOMETRIKA, 100(3), 681–694.

A Robust Method for Estimating Optimal Treatment Regimes

BIOMETRICS, 68(4), 1010–1018.

Estimating optimal treatment regimes from a classification perspective

Stat, 1(1), 103–114.

Mixed model analysis of censored longitudinal data with flexible random-effects density

BIOSTATISTICS, 13(1), 61–73.

Connections between survey calibration estimators and semiparametric models for incomplete data discussion

International Statistical Review, 79(2), 221–223.

Improved Doubly Robust Estimation When Data Are Monotonely Coarsened, with Application to Longitudinal Studies with Dropout

BIOMETRICS, 67(2), 536–545.

Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial

BIOSTATISTICS, 12(2), 258–269.

Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring

LIFETIME DATA ANALYSIS, 17(4), 566–593.

A Generalized Estimator of the Attributable Benefit of an Optimal Treatment Regime

BIOMETRICS, 66(2), 512–522.

Multiple Imputation Approaches for the Analysis of Dichotomized Responses in Longitudinal Studies with Missing Data

BIOMETRICS, 66(4), 1202–1208.

Improving efficiency and robustness of the doubly robust estimator for a population mean with incomplete data

BIOMETRIKA, 96(3), 723–734.

Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: A principled yet flexible approach

Tsiatis, A. A., Davidian, M., Zhang, M., & Lu, X. (2008, October 15). STATISTICS IN MEDICINE, Vol. 27, pp. 4658–4677.

Empirical estimation of life expectancy from large clinical trials: Use of left-truncated, right-censored survival analysis methodology

STATISTICS IN MEDICINE, 27(26), 5525–5555.

Improving efficiency of inferences in randomized clinical trials using auxiliary covariates

BIOMETRICS, 64(3), 707–715.

Improving the efficiency of the log-rank test using auxiliary covariates

BIOMETRIKA, 95(3), 679–694.

Optimal two-stage group-sequential designs

JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 138(2), 489–499.

Quality of life with defibrillator therapy or amiodarone in heart failure

NEW ENGLAND JOURNAL OF MEDICINE, 359(10), 999–1008.

Adaptive two-stage designs in phase II clinical trials

STATISTICS IN MEDICINE, 25(19), 3382–3395.

Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure - Results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

CIRCULATION, 114(2), 135–142.

Information-based monitoring of clinical trials

Tsiatis, A. A. (2006, October 15). STATISTICS IN MEDICINE, Vol. 25, pp. 3236–3244.

On closed form semiparametric estimators for measurement error models

Statistica Sinica, 16(1), 183–193.

Semiparametric efficient estimation of survival distributions in two-stage randomisation designs in clinical trials with censored data

BIOMETRIKA, 93(1), 163–177.

Semiparametric theory and missing data

New York: Springer.

Semiparametric transformation models for the case-cohort study

BIOMETRIKA, 93(1), 207–214.

Comparison between two partial likelihood approaches for the competing risks model with missing cause of failure

LIFETIME DATA ANALYSIS, 11(1), 29–40.

Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus

AMERICAN HEART JOURNAL, 149(3), 434–443.

Locally efficient semiparametric estimators for generalized skew-elliptical distributions

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 100(471), 980–989.

Locally-efficient robust estimation of haplotype-disease association in family-based studies

BIOMETRIKA, 92(3), 559–571.

Semiparametric estimation of treatment effect in a pretest-posttest study with missing data

Statistical Science, 20(3), 261–282.

Semiparametric estimators for the regression coefficients in the linear transformation competing risks model with missing cause of failure

BIOMETRIKA, 92(4), 875–891.

Semiparametric inference in observational duration-response studies, with duration possibly right-censored

BIOMETRIKA, 92(3), 605–618.

Statistical issues arising in the Women's Health Initiative - Discussion

Tsiatis, A. A., & Davidian, M. (2005, December). BIOMETRICS, Vol. 61, pp. 933–935.

Differential Treatment Benefit of Platelet Glycoprotein IIb/IIIa Inhibition With Percutaneous Coronary Intervention Versus Medical Therapy for Acute Coronary Syndromes

Circulation, 109(5), 641–646.

Estimating mean response as a function of treatment duration in an observational study, where duration may be informatively censored

BIOMETRICS, 60(2), 315–323.

Joint modeling of longitudinal and time-to-event data: An overview

Statistica Sinica, 14(3), 809–834.

Locally efficient semiparametric estimators for functional measurement error models

Biometrika, 91(4), 835–848.

Marginal structural models for analyzing causal effects of time-dependent treatments: An application in perinatal epidemiology

AMERICAN JOURNAL OF EPIDEMIOLOGY, 159(10), 926–934.

Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT Substudy)

AMERICAN JOURNAL OF CARDIOLOGY, 94(7), 926–929.

Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials

BIOMETRICS, 60(1), 124–133.

The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease

ACC Current Journal Review, 13(4), 11–12.

The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease

Journal of the American College of Cardiology, 43(4), 576–582.

On the inefficiency of the adaptive design for monitoring clinical trials

BIOMETRIKA, 90(2), 367–378.

Semiparametric estimation of treatment effect in a pretest-posttest study

BIOMETRICS, 59(4), 1046–1055.

A semiparametric likelihood approach to joint modeling of longitudinal and time-to-event data

BIOMETRICS, 58(4), 742–753.

An estimator for the proportional hazards model with multiple longitudinal covariates measured with error

Biostatistics (Oxford, England), 3(4), 511–528.

Effects of insulin in relatives of patients with type 1 diabetes mellitus

New England Journal of Medicine, 346(22), 1685–1691.

Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials

BIOMETRICS, 58(1), 48–57.

Median regression with censored cost data

BIOMETRICS, 58(3), 643–649.

Multiple imputation methods for testing treatment differences in survival distributions with missing cause of failure

Biometrika, 89(1), 238–244.

A semiparametric estimator for the proportional hazards model with longitudinal covariates measured with error

BIOMETRIKA, 88(2), 447–458.

Causal inference on the difference of the restricted mean lifetime between two groups

BIOMETRICS, 57(4), 1030–1038.

Computationally simple accelerated failure time regression for interval censored data

BIOMETRIKA, 88(3), 703–711.

Efficiency study of estimators for a treatment effect in a pretest-posttest trial

AMERICAN STATISTICIAN, 55(4), 314–321.

Flexible sample size considerations using information-based interim monitoring

DRUG INFORMATION JOURNAL, 35(4), 1095–1112.

Interim monitoring of group sequential trials using spending functions for the type I and type II error probabilities

DRUG INFORMATION JOURNAL, 35(4), 1113–1121.

Multiple imputation methods for estimating regression coefficients in the competing risks model with missing cause of failure

BIOMETRICS, 57(4), 1191–1197.

Testing equality of survival functions of quality-adjusted lifetime

BIOMETRICS, 57(3), 861–867.

Using auxiliary time-dependent covariates to recover information in nonparametric testing with censored data

LIFETIME DATA ANALYSIS, 7(2), 125–141.

Utilizing propensity scores to estimate causal treatment effects with censored time-lagged data

BIOMETRICS, 57(4), 1207–1218.

Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes

CIRCULATION, 101(4), 366–371.

Estimating medical costs with censored data

BIOMETRIKA, 87(2), 329–343.

Estimating the distribution of quality-adjusted life with censored data

Tsiatis, A. A. (2000, April). AMERICAN HEART JOURNAL, Vol. 139, pp. S177–S181.

Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis

AIDS Research and Human Retroviruses, 16(12), 1123–1133.

Testing for differences in survival with delayed ascertainment

BIOMETRICS, 56(1), 145–153.

Using conditional logistic regression to fit proportional odds models to interval censored data

BIOMETRICS, 56(2), 511–518.

Efficient estimation of the distribution of quality-adjusted survival time

BIOMETRICS, 55(4), 1101–1107.

Estimating the parameters in the Cox model when covariate variables are measured with error

BIOMETRICS, 54(4), 1407–1419.

Semiparametric efficient estimation in the generalized odds-rate class of regression models for right-censored time-to-event data

Lifetime Data Analysis, 4(4), 355–391.

Use of simulation and bootstrap in information-based group sequential studies

Statistics in Medicine, 17(1), 75–87.

A consistent estimator for the distribution of quality adjusted survival time

BIOMETRIKA, 84(2), 339–348.

A joint model for survival and longitudinal data measured with error

BIOMETRICS, 53(1), 330–339.

Semiparametric efficiency and its implication on the design and analysis of group-sequential studies

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 92(440), 1342–1350.